Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.92
+0.88 (4.88%)
Nov 24, 2025, 1:44 PM EST - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.04 billion as of November 24, 2025. Its market cap has decreased by -19.82% in one year.
Market Cap
1.04B
Enterprise Value
730.75M
1-Year Change
-19.82%
Ranking
Category
Stock Price
$18.92
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.04B, an increase of 11.25%. That is a compound annual growth rate of 9.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 988.27M | 4.26% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |